Novavax, Inc (NASDAQ:NVAX) traded at $9.32 at close of the session on Monday, January 27 and made an upward move of 1.08% on its previous day’s price. Looking at the stock we see that its previous close was $9.22 and the beta (5Y monthly) reads
Novavax, Inc (NASDAQ:NVAX) shares, rose in value, with the stock price down by -0.15% to the previous day’s close as strong demand from buyers drove the stock to $9.54. Actively observing the price movement in the recent trading, the stock is buoying the session at
Shares of US biotech company Novavax at the August 5 aftermarket trading rose 5%, then plunged more than 17% to $204.76 each. The plunge was in response to the upcoming transfer of the application to the United States Food and Drug Administration (FDA) for approval
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
